Table 3.

MI-BCa tumor staging classification performance in patients in test set (n = 130; Table 1A)

Tumor stage*Specificity (95% CI)Sensitivity (95% CI)
Tis (n = 6)83% (36-97)
pTa (n = 40)90% (76-97)
T1 (n = 22)86% (65-97)
T2 (n = 39)49% (32-65)
T3 (n = 18)50% (26-74)
T4 (n = 5)80% (29-97)
  • *Bladder tumor stage (Sobin et al., 1997).